all benefits of retatrutide Today, we shared new data from two Phase 3 trials retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Eli Lilly's retatrutide shows promising

GLP-1 Drugs: The Science and the Scarcity How breakthroughs in GLP-1 science are creating new challenges

Skugor et al., 2019)

Thanks to the glitchy patient portal, the tracking information froze and never updated past the initial shipping status, even after delivery

Franklin, J.C

Lee YS, Park MS, Choung JS et al (2012) Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes

If you find that the blood glucose levels remain high despite the first bolus from the pump, you should give the second correction dose using an insulin pen and NOT from the pump